Even in these unprecedented times research, learning, and knowledge exchange in precision oncology research must continue, just as routine patient testing and treatment must.
Our educational symposium will help you understand the value of NGS in lymphoid research
The European Association for Haematopathology (EAHP) and the Society for Hematopathology (SH), held the 20th Meeting of the EAHP as a virtual event from the 24th to 29th April.
As part of the programme, Thermo Fisher Scientific hosted an educational industry symposium on the uses of next generation sequencing (NGS) in lymphoid research.
Our customers shared their valuable experience on the value of NGS:
Lymphoma NGS molecular characterisation—assessing the journey to answers
Marianne Grantham, Head of Cytogenetics and Molecular Haematology, Barts Health NHS Trust, UK
The time is NOW for NGS-based clonality testing
Michael Hummel, Charité – Universitätsmedizin Berlin, Institute of Pathology - Molecular Diagnostics, Germany
Next generation sequencing for B cell receptor sequencing in Multiple Myeloma: uses and impact
Dr Artur Kowalik, Head Department Molecular Diagnostics, Holy Cross Cancer Center, Poland
Watch dozens of NGS education presentations at your convenience
We recently hosted over a thousand professionals for our third OncomineWorld virtual NGS education meeting in April. Thank you to those who attended the live event. If you missed the meeting or you would like to revisit our programming, you can now access all event features on demand.
- Earn continuing education (CE) credits from dozens of educational talks
- Explore interactive virtual laboratories to learn about the many applications of NGS in oncology research
- See the latest research in our poster hall
- And much more
Don't forget—you can also access on-demand presentations from our 2020 sessions as well.
Thank you for visiting our booth at ESP/IAP 2020 Virtual Congress
If you did not have a chance to visit our booth or symposium or would like access to the scientific talks presented at the conference, here is an opportunity to download all the information you need.
Advancing precision oncology requires effective biomarker testing and actionable insights that drive better patient outcomes in the future. With next-generation sequencing (NGS), you can now get the insights you need when you need them—in one day not weeks. Learn more about thought leaders experiences.
It's NGS, as fast and easy as IHC or PCR
The Oncomine Precision Assay on the Ion Torrent Genexus System features a complete next-generation sequencing (NGS) testing workflow. Now every lab can go from specimen to report in a single day, providing a comprehensive genomic profile at a speed never possible before. This allows you to deliver NGS results at the same time as other single-gene methods, such as immunohistochemistry (IHC) and PDL1 biomarker test. The hands-off, set-up-and-go workflow makes NGS accessible, even if your lab is new to the technology.
NGS biomarker testing: time matters—No longer need to wait for weeks, this now can happen in days
Watch the ESMO symposium now on demand.
Introduction: genomic profiling is driving precision oncology
UNI Hospital, Basel, Switzerland
Gabriela Fernandes, MD
Pulmonology Department, Centro Hospitalar, Universitário de São João, Alameda Prof. Hernâni Monteiro, Portugal
Department Head of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan
UNI Hospital, Basel, Switzerland
Discover how NGS can be as quick and easy as immunohistochemistry.
For Research Use Only. Not For Use In Diagnostic Procedures.